Form 8-K - Current report:
SEC Accession No. 0001193125-22-003142
Filing Date
2022-01-06
Accepted
2022-01-06 07:30:32
Documents
13
Period of Report
2021-12-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d274995d8k.htm   iXBRL 8-K 24863
2 EX-99.1 d274995dex991.htm EX-99.1 15601
  Complete submission text file 0001193125-22-003142.txt   169839

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pstv-20211231.xsd EX-101.SCH 2914
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pstv-20211231_lab.xml EX-101.LAB 18137
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pstv-20211231_pre.xml EX-101.PRE 11422
7 EXTRACTED XBRL INSTANCE DOCUMENT d274995d8k_htm.xml XML 3395
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 737.255.7194
PLUS THERAPEUTICS, INC. (Filer) CIK: 0001095981 (see all company filings)

EIN.: 330827593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34375 | Film No.: 22513631
SIC: 3841 Surgical & Medical Instruments & Apparatus